12 December 2023
12 December 2023
The diagnostic and therapeutic device is expected to commercially launch in the first half of 2024.
The sample preparation solutions include KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit.
Vueway has halve the dose of gadolinium compared to standard agents but has shown greater enhancement of contrast in clinical trials.
The platform could identify responses to 99 viruses and 39 types of bacteria during proof-of-concept study.
The implantation has been conducted as part of the company’s EFICAS clinical study.
TLX250-CDx is Telix's first-in-class, non-invasive investigational positron emission tomography imaging agent.
A study shared at ASH saw lupus and sclerosis patients make marked recoveries through CAR-T therapy initally targeted at blood cancers.
Swedish company Verigraft is personalising vein transplants to remove the need for immune-suppressive agents.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Cybersecurity is a growing market in the medical devices sector for several reasons. Medical devices often collect and contain vulnerable data, such as patient medical information. Legacy medical devices are a cause for concern because they likely were not designed with cyberattacks in mind. With the adoption of EHR systems, telemedicine measures, mobile health apps, and other connected devices, there is increased vulnerability to cyberattacks.
Give your business an edge with our leading industry insights.
